A high TMB potentially signifies a higher number of neoantigens, which may boost the immune system’s ability to recognize and attack tumor cells, thereby enhancing the efficacy of immunotherapies such as PD-1/PD-L1 inhibitors.[4,5]. Here, PDCD1 is linked to neoplasm.